Last Modified: 04-12-2020
Result:
For the further queries regarding patent, please email to
For the further queries regarding patent, please email to
Composition Comprising Rhizoma Coptidis, Cortex Pellodendri and Fructus Gardeniae and For Treating Neurodegenerative Diseases
包含黃連、黃柏以及梔子並且用於治療神經變性疾病的組合物
( School of Chinese Medicine )
包含黃連、黃柏以及梔子並且用於治療神經變性疾病的組合物
( School of Chinese Medicine )
KTO ref no.
A61-LM-Hljd-US01
Application No.
14/303,622
Patent no.
9,375,457
Filing date
13-06-2014
Priority date
17-06-2013; 13-06-2013
Status
Granted
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
Inventor(s)
Min LI; Leilei CHEN; Siva Sundara Kumar DURAIRAJAN; Liangfeng LIU; Juxian SONG
Long-Acting Gel Composition Comprising Blood Sugar Reducing Active Component and Capable of Controlling and Releasing Liposome, and preparation Method Thereof
( School of Chinese Medicine )
( School of Chinese Medicine )
KTO ref no.
A61-YZ-Insu-JP01
Application No.
2016-553609
Patent no.
JP 6305555
Filing date
20-10-2014
Priority date
19-02-2014
Status
Granted
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
Japan
Inventor(s)
Zhijun YANG; Zhaoxiang BIAN; Aiping LU; 王芷君; 陳曉昱
Anticancer Miliusane Derivatives
( School of Chinese Medicine )
( School of Chinese Medicine )
KTO ref no.
A61-ZH-Mili-US02
Application No.
14/927,485
Patent no.
9,695,141
Filing date
30-10-2015
Priority date
05-06-2012
Status
Granted
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
Inventor(s)
Hongjie ZHANG
ANTI- ESOPHAGEAL CANCER COMPOUND AND METHOD OF USE THEREOF
( School of Chinese Medicine )
( School of Chinese Medicine )
KTO ref no.
A61-BZ-Root-US01
Application No.
15/190,367
Patent no.
US 9,655,913 B2
Filing date
23-06-2016
Priority date
23-06-2015
Status
Granted
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
Inventor(s)
Chengyuan LIN; Zhijun YANG; Zhaoxiang BIAN; Sun Chi Albert CHAN; Huaixue MU; Aiping LU; Jinjin WANG
(+)-3’-Angeloyloxy-4’-keto-3’,4’-dihydroseselin for Treating Inflammation
( School of Chinese Medicine )
( School of Chinese Medicine )
KTO ref no.
A61-BZ-Pbld-US01
Application No.
14/742,727
Patent no.
9,408,828
Filing date
18-06-2015
Priority date
18-06-2014
Status
Granted
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
Inventor(s)
Chengyuan LIN; Zhaoxiang BIAN; Sun Chi Albert CHAN; Huaixue MU; Hongxi XU; Shilin CHEN; Dajian YANG; Linfang HUANG; Aiping LU; Quanbin HAN
Total : 45
Technology areas
Technology areas
Enquiry
Address
DLB 825, David C. Lam Building, 34 Renfrew Road, Shaw Campus,
Hong Kong Baptist University, Kowloon Tong, Hong Kong